These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 30013258)
1. Changes in antioxidant status associated with haemodialysis in chronic kidney disease. Ogunleye A; Akinbodewa AA; Adejumo OA; Oluwafemi TT; Akinfaderin DA Ghana Med J; 2018 Mar; 52(1):29-33. PubMed ID: 30013258 [TBL] [Abstract][Full Text] [Related]
2. The effect of a membrane dialyzer during hemodialysis on the antioxidant status and lipid peroxidation of patients with end-stage renal disease. Ogunro PS; Olujombo FA; Ajala MO; Oshodi TT Saudi J Kidney Dis Transpl; 2014 Nov; 25(6):1186-93. PubMed ID: 25394434 [TBL] [Abstract][Full Text] [Related]
3. Higher levels of antioxidant defenses in enalapril-treated versus non-enalapril-treated hemodialysis patients. de Cavanagh EM; Ferder L; Carrasquedo F; Scrivo D; Wassermann A; Fraga CG; Inserra F Am J Kidney Dis; 1999 Sep; 34(3):445-55. PubMed ID: 10469854 [TBL] [Abstract][Full Text] [Related]
4. Antioxidant and oxidative stress indices in dialysis-dependent acute renal failure. Balakrishnan VS; Blumberg J; Pereira BJ; Jaber BL Blood Purif; 2003; 21(3):213-9. PubMed ID: 12784046 [TBL] [Abstract][Full Text] [Related]
5. Oxidative stress markers and C-reactive protein in pediatric patients on hemodialysis. Elshamaa MF; Sabry S; Nabih M; Elghoroury EA; El-Saaid GS; Ismail AA Ann Nutr Metab; 2009; 55(4):309-16. PubMed ID: 19828941 [TBL] [Abstract][Full Text] [Related]
6. Effect of dialysis on plasma total antioxidant capacity and lipid peroxidation products in patients with end-stage renal failure. Samouilidou E; Grapsa E Blood Purif; 2003; 21(3):209-12. PubMed ID: 12784045 [TBL] [Abstract][Full Text] [Related]
7. Influence of Hemodialysis on Lipid Peroxidation, Enzymatic and Non-Enzymatic Antioxidant Capacity in Chronic Renal Failure Patients. Zargari M; Sedighi O Nephrourol Mon; 2015 Jul; 7(4):e28526. PubMed ID: 26539417 [TBL] [Abstract][Full Text] [Related]
8. Leukocyte activation markers and oxidative status in chronic kidney disease. Carollo C; Lo Presti R; Caimi G Minerva Urol Nefrol; 2013 Mar; 65(1):69-76. PubMed ID: 23538312 [TBL] [Abstract][Full Text] [Related]
9. N-acetylcysteine reduces malondialdehyde levels in chronic hemodialysis patients--a pilot study. Trimarchi H; Mongitore MR; Baglioni P; Forrester M; Freixas EA; Schropp M; Pereyra H; Alonso M Clin Nephrol; 2003 Jun; 59(6):441-6. PubMed ID: 12834176 [TBL] [Abstract][Full Text] [Related]
11. Lipid peroxidation and antioxidant enzymes in children on maintenance dialysis. Zwołińska D; Grzeszczak W; Szczepańska M; Kiliś-Pstrusińska K; Szprynger K Pediatr Nephrol; 2006 May; 21(5):705-10. PubMed ID: 16518626 [TBL] [Abstract][Full Text] [Related]
12. Effect of hemodialysis on total antioxidant status of chronic renal failure patients in government hospitals in Lagos Nigeria. Ajala MO; Ogunro PS; Odun A Niger J Clin Pract; 2011; 14(2):154-8. PubMed ID: 21860130 [TBL] [Abstract][Full Text] [Related]
13. Oxidative stress markers and C-reactive protein in end-stage renal failure patients on dialysis. Samouilidou EC; Grapsa EJ; Kakavas I; Lagouranis A; Agrogiannis B Int Urol Nephrol; 2003; 35(3):393-7. PubMed ID: 15160547 [TBL] [Abstract][Full Text] [Related]
14. Plasma total antioxidant capacity in hemodialyzed patients and its relationships to other biomarkers of oxidative stress and lipid peroxidation. Gerardi G; Usberti M; Martini G; Albertini A; Sugherini L; Pompella A; Di LD Clin Chem Lab Med; 2002 Feb; 40(2):104-10. PubMed ID: 11939481 [TBL] [Abstract][Full Text] [Related]
15. Free and total plasma malondialdehyde in chronic renal insufficiency and in dialysis patients. De Vecchi AF; Bamonti F; Novembrino C; Ippolito S; Guerra L; Lonati S; Salini S; Aman CS; Scurati-Manzoni E; Cighetti G Nephrol Dial Transplant; 2009 Aug; 24(8):2524-9. PubMed ID: 19264746 [TBL] [Abstract][Full Text] [Related]
16. [The effect of hemodialysis on some parameters of the antioxidant system in the blood of patients with chronic renal failure]. Olszewska M Ann Acad Med Stetin; 2004; 50(1):41-52. PubMed ID: 16871743 [TBL] [Abstract][Full Text] [Related]
17. Endothelial function and oxidative stress in chronic kidney disease of varying severity and the effect of acute hemodialysis. Khaira A; Mahajan S; Kumar A; Saraya A; Tiwari SC; Prakash S; Gupta A; Bhowmik D; Agarwal SK Ren Fail; 2011; 33(4):411-7. PubMed ID: 21529270 [TBL] [Abstract][Full Text] [Related]
19. How the duration period of erythropoietin treatment influences the oxidative status of hemodialysis patients. Dimitrijevic ZM; Cvetkovic TP; Djordjevic VM; Pavlovic DD; Stefanovic NZ; Stojanovic IR; Paunovic GJ; Velickovic-Radovanovic RM Int J Med Sci; 2012; 9(9):808-15. PubMed ID: 23136545 [TBL] [Abstract][Full Text] [Related]
20. Influence of single hemodialysis session on serum paraoxonase-1, arylesterase activity, total oxıdant status and total antioxidant status. Yildiz G; Aydin H; Mağden K; Yilmaz A; Hür E; Candan F Minerva Med; 2014 Feb; 105(1):79-87. PubMed ID: 24572453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]